FDAnews Device Daily Bulletin

Quest Diagnostics Announces Availability of TERC Test for Cervical Cancer

Sept. 4, 2012
A A
Quest Diagnostics, the world’s leading provider of diagnostic testing, information and services, today announced the availability of a new laboratory test that identifies molecular changes to cervical cells that increase the likelihood a woman may develop cervical cancer.
News-Medical